Videos

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.

Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.

Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.

At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.

Chase Johnston, VP of Operations at Arjuna Natural, explains what matters for product formulation as active nutrition extends past athletes to the everyday consumer.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.

Perimenopause can last four to eight years and bring anywhere from 30 to 100 reported symptoms, which makes it one of the hardest life stages for supplement brands to formulate for.

In this teaser, Karin Linnewiel Hermoni discusses formulation traps for perimenopause products.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.

Christopher Bailey, PhD, discusses current trends in the testosterone support category and introduces a proprietary aged garlic extract standardized for the bioactive S-allyl-cysteine (SAC).

Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.

Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.

Live from the Future Nutra Innovation Summit, Cassie Evans, PhD, RD, explains what sets Helaina's effera human-identical lactoferrin apart in multiple aspects.

Ahead of her keynote at The Outlook on Active Nutrition, Michelle Arent, USC's Olympic sports performance nutrition director, shares her rigorous supplement vetting process, industry gaps in usability, and a preview of her presentation.

In the eighth episode, Nicholas Saraceno examines how social media has reshaped where people get their health and supplement information, from AI-generated "wellness experts" running fabricated ads to registered dietitians and physicians building their own followings to counter it.

The panel closes by discussing which ingredient pairings show real biological synergy, whether brands are thinking about nutrient absorption competition, and why the budget-conscious end of the market may be the industry's most overlooked opportunity.

Franziska Weichmann, PhD, discusses the microcirculation, antioxidant, and gene-expression research behind Pycnogenol's effects on scalp and skin barrier health, ongoing mechanistic studies, and how the ingredient fits into combination formulas.

From effervescent powders to protein donuts, panelists discuss how brands are using format and flavor innovation, including unexpected soda-inspired flavors, to turn daily supplementation into something consumers look forward to.

Douglas Kalman, PhD, explains how to support GLP-1 user nutrition, previewing his upcoming session on formulating for muscle preservation at Outlook on Active Nutrition.

The panel identifies the categories formulators are overlooking, from postpartum and infant nutrition to functional kids' snacks, and debates whether creatine can finally crack shelf-stable beverage formats.

A deep dive into why women's health products are consolidating multiple benefits into single formulas, and how brands are weighing all-in-one convenience against the commercial risks of trying to do too much.

Founder Joey Savage and partnerships director Ben Kane discuss educational sessions, product testing, and industry innovation ahead of the September event.

Franziska Weichmann, PhD, unpacks a double-blind study's surprising hair density and scalp health findings, and explains why timing, external stressors, and long-term use all valuable.

The panel unpacks what "healthy aging" really means to consumers, why joint health hasn't grown as fast as expected, and why testosterone interest is suddenly resurging across age groups and genders.

Ben Kane, president of PricePlow, previews his discussion at The Outlook on Active Nutrition, exploring where regulation, innovation, and industry trends collide.